Observational Study Of The Long-Term Effect Of Macugen In Patients With Wet Age-Related Macular Degeneration

• Status: Completed
• Trial end date: 2009-12-01
• Target enrollment: 0
• Participant gender: All

Summary

Long-term observational study to assess the safety, efficacy and quality of life of patients with neovascular age-related macular degeneration (AMD) under Macugen treatment.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Pfizer

Criteria

Inclusion Criteria:

• patients with neovascular age-related macular degeneration

Exclusion Criteria:

• none